Slashdot

Slashdot
News for nerds, stuff that matters
Updated: 12 min 34 sec ago

Former HP CEO Carly Fiorina Considering US Presidential Run

Wed, 26/11/2014 - 3:23pm
McGruber writes: Fired HP CEO and failed Republican Senate candidate Carly Fiorina is "actively exploring a 2016 presidential run." Fiorina has been "talking privately with potential donors, recruiting campaign staffers, courting grass-roots activists in early caucus and primary states, and planning trips to Iowa and New Hampshire starting next week."

Read more of this story at Slashdot.








Former HP CEO Carly Fiorina Considering US Presidential Run

Wed, 26/11/2014 - 3:23pm
McGruber writes: Fired HP CEO and failed Republican Senate candidate Carly Fiorina is "actively exploring a 2016 presidential run." Fiorina has been "talking privately with potential donors, recruiting campaign staffers, courting grass-roots activists in early caucus and primary states, and planning trips to Iowa and New Hampshire starting next week."

Read more of this story at Slashdot.








Former HP CEO Carly Fiorina Considering US Presidential Run

Wed, 26/11/2014 - 3:23pm
McGruber writes: Fired HP CEO and failed Republican Senate candidate Carly Fiorina is "actively exploring a 2016 presidential run." Fiorina has been "talking privately with potential donors, recruiting campaign staffers, courting grass-roots activists in early caucus and primary states, and planning trips to Iowa and New Hampshire starting next week."

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.








Canada's Ebola Vaccine Nets Millions For Tiny US Biotech Firm

Wed, 26/11/2014 - 2:40pm
Anita Hunt (lissnup) writes: Iowa-based NewLink Genetics has secured a US$50million deal with pharmaceutical giant Merck for the experimental Ebola vaccine developed by Canadian government scientists. NewLink bought the exclusive commercial licensing rights to Canada's VSV-EBOV in 2010 with a milestone payment of just US$205,000. This is an interesting new twist in a story we've discussed previously, and which continues to draw media attention.

Read more of this story at Slashdot.